SWOG S2107: Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAF V600E metastatic and/or unresectable colorectal cancer.

Authors :: Morris, Van K.
Guthrie, Katherine A.
Kopetz, Scott
Breakstone, Rimini
Karasic, Thomas Benjamin
Hu, Zishuo Ian
Colby, Sarah
Fakih, Marwan
Gholami, Sepideh
Gold, Philip Jordan
Philip, Philip A.
Source :: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, pTPS234-TPS234, 235p
Publication Year :: 2024

Full Text Access

Tools